Lethal autoantibodies: Do they exist?*

Authors

  • Varvara Ryabkova St. Petersburg State University, 7–9, Universitetskaya nab., St. Petersburg, 199034, Russian Federation

DOI:

https://doi.org/10.21638/spbu11.2019.413

Abstract

Heart rhythm disturbances belong to the most complex and pressing problems of cardiology. Sudden cardiac death (SCD) is an unexpected death due to cardiac causes that occurs in a short time period (generally within 1 hour of acute manifestations’ onset). Tanatogenesis in this case is linked to ventricular arrhythmias. Patients with cardiomyopathies, myocarditis, ischemic heart disease and inherited cardiac channelopathies are at risk of SCD. However,a certain percentage of autopsy-negative cases of SCD in children and young adults remain unexplained even after a post-mortem genetic testing. Autoantibodies against cardiac proteins may be potentially involved in the pathogenesis of different heart diseases and in the occurrence of cardiac arrhythmias, including those, which can lead to SCD. In this review the prevalence of some antimyocardial autoantibodies in patients with different heart diseases and their mechanistical relevance are addressed. A classification of these autoantibodies is proposed, and their molecular and cellular effects are discussed.

Keywords:

autoantibodies, autoimmunity, arrhythmia, sudden cardiac death, channelopathies, G-protein coupled receptors

Downloads

Download data is not yet available.
 

References


References

Ryabkova V.A., Shubik Y.V., Erman M.V., Churilov L.P., Kanduc D., Shoenfeld Y. Lethal immunoglobulins: Autoantibodies and sudden cardiac death. Autoimmunity Reviews, 2019, vol. 18, pp. 415–425.

Bornholz B., Roggenbuck D., Jahns R., Boege F. Diagnostic and therapeutic aspects of β1-adrenergic receptor autoantibodies in human heart disease. Autoimmunity Reviews, 2014, vol. 13, no. 9, pp. 954–962.

Baba A., Yoshikawa T., Ogawa S. Autoantibodies produced against sarcolemmal Na-K-ATPase: possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy. Journal of the American College of Cardiology, 2002, vol. 6, pp. 1153–1159.

Lazzerini P.E., Yue Y., Srivastava U., Fabris F., Capecchi P.L., Bertolozzi I. et al. Arrhythmogenicity of Anti-Ro/SSAAntibodies in Patients With Torsades de Pointes. Circulation: Arrhythmia and Electrophysiology, 2016, vol. 9, no. 4, pp. e003419.

Bagnall R.D., Weintraub R.G., Ingles J. et al. A Prospective Study of Sudden Cardiac Death amongChildren and Young Adults. The New England Journal of Medicine, 2016, vol. 374, pp. 2441–2452.

Downloads

Published

2020-06-15

How to Cite

Ryabkova, V. (2020). Lethal autoantibodies: Do they exist?*. Vestnik of Saint Petersburg University. Medicine, 14(4), 310–313. https://doi.org/10.21638/spbu11.2019.413

Issue

Section

Internal medicine